Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

SHA:603351 Revenue

Nanjing Well Pharmaceutical Group had revenue of 356.30M CNY in the quarter ending March 31, 2026, with 1.88% growth. This brings the company's revenue in the last twelve months to 1.34B, up 1.90% year-over-year. In the year 2025, Nanjing Well Pharmaceutical Group had annual revenue of 1.34B with 2.95% growth.

• Revenue (ttm): 1.34B
• Revenue Growth: +1.90%
• P/S Ratio: 2.74
• Revenue / Employee: 1.89M
• Employees: 711
• Market Cap: 3.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.34B	38.28M	2.95%
Dec 31, 2024	1.30B	140.91M	12.19%
Dec 31, 2023	1.16B	44.83M	4.03%
Dec 31, 2022	1.11B	68.70M	6.59%
Dec 31, 2021	1.04B	306.24M	41.61%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error